Therapeutic Plasma Exchange in NYC

Therapeutic plasma exchange, or TPE, is a physician-supervised procedure that removes the plasma fraction of your blood and replaces it with fresh albumin solution, with the goal of reducing circulating inflammatory proteins, aged plasma factors, and other plasma-borne burden that accumulates over time. Does it work? The strongest direct human evidence we have says yes, but within limits: a randomized controlled trial published in Aging Cell in May 2025 found an average biological age reduction of 2.61 years with TPE plus IVIG, and 1.32 years with TPE alone, in adults over 50 (when used in the right setting). This is not a first step for most patients. In my view, it makes the most sense for patients who have already handled the basics and want a measured intervention, not a wellness fantasy.

This page covers Liondale's specific program: what we do, how we measure response, and who we think is a good fit. If you are comparing all three NYC providers, see our NYC TPE provider guide. If cost is the first question, our TPE cost page covers that directly.

What TPE Actually Does

TPE is an apheresis procedure, not an IV drip and not a spa treatment. Blood is drawn continuously through an apheresis machine, the plasma is separated from your blood cells, that plasma is discarded, and fresh albumin replaces it before your blood cells are returned. One or two IV lines are typically used (depending on access and flow), and a certified apheresis nurse monitors the session while your vital signs are tracked throughout.

The treatment itself usually takes two to three hours. Most patients sit comfortably, read, work, or rest while the machine does the separation process. It sounds technical because it is technical. But the basic idea is simple: remove the circulating plasma burden, replace it with clean fluid, and let the body rebuild from there.

IVIG, or intravenous immunoglobulin, may be added alongside TPE in some cases. It is not a standard add-on and it is not something I think should be sold like an upgrade. It is a clinical decision. The 2025 trial used TPE with IVIG for the 2.61-year biological age result, while TPE alone produced 1.32 years. That difference matters, but it does not mean IVIG belongs in every protocol.

Patients sometimes hear about plasma exchange and assume it is some variation of detox medicine. It is not. TPE has been used in hospital medicine for decades because it physically changes what is circulating in the bloodstream. That is why the conversation around it is serious.

What the Evidence Shows

The study that changed this conversation was published by Fuentealba and colleagues in Aging Cell in May 2025. It enrolled 42 healthy adults over 50 in a randomized, placebo-controlled trial, which is a much higher bar than anecdote or celebrity enthusiasm (and far better than the usual longevity marketing deck). Participants who received TPE plus IVIG saw an average biological age reduction of 2.61 years. TPE alone produced an average reduction of 1.32 years. The measurements came from epigenetic clocks, which are DNA methylation-based biomarkers used to estimate biological age.

Only two participants discontinued. That is a strong signal for tolerability, especially for an elective procedure. The paper also noted diminishing returns after three sessions, which I appreciate because it pushes back against the lazy idea that more is necessarily better. It often is not.

The earlier human work mattered too. Kim and colleagues published Old plasma dilution reduces human biological age in GeroScience in 2022, helping establish the mechanistic case that plasma dilution could shift biological aging markers in the right direction. The 2025 trial built on that foundation and gave us something the longevity field rarely gets: controlled human data.

"Science is showing that while chronological aging is inevitable, biological aging is malleable. There's a part of it that you can fight."

- Dr. Eric Verdin, Co-Founder of Circulate Health and CEO of the Buck Institute for Research on Aging

That quote is compelling, and I agree with the spirit of it. But here is the necessary caveat. This is one trial with 42 participants. Epigenetic clocks are biomarkers, not hard clinical outcomes like fewer heart attacks, fewer hospitalizations, or longer lifespan. So no, this does not prove TPE extends life. What it does show is measurable movement in a serious aging biomarker framework, which is more than most longevity interventions can claim.

If you want the deeper evidence discussion, read our clinical trial evidence breakdown. And if you are comparing TPE to other options, our TPE versus other longevity treatments guide puts the tradeoffs in plain English.

Who Is a Good Candidate

I do not think TPE is where most people should begin. If your sleep is erratic, your diet is inconsistent, your training is nonexistent, and stress is running the show, that is where the work is. TPE can be a meaningful next move, but not always the first one.

The first strong candidate profile is the proactive optimizer. This is the Manhattan patient who has already done the obvious work, often through anti-aging medicine, concierge care, or a carefully managed performance routine, and wants an intervention with published human trial data behind it. They are not looking for hype. They want something measurable.

The second profile is the patient with chronic inflammation symptoms that do not fit neatly on a standard lab sheet. Persistent fatigue. Brain fog. Achiness that lingers. Slower recovery after workouts or travel. A general sense that capacity dropped and never fully came back (patients usually describe it more bluntly than that). TPE is interesting here because it targets the circulating inflammatory burden itself, not just the symptoms wrapped around it.

The third profile is the high performer with unexplained decline. Biomarkers are starting to drift, stamina is not what it was, focus feels less durable, and the patient wants to intervene before those shifts harden into something more difficult. That is often the right moment to have the conversation.

Who should not do TPE? Patients with active bleeding disorders, certain clotting factor deficiencies, severe hemodynamic instability, or albumin allergy are not candidates. Patients on anticoagulants or some immunosuppressants need individual review. And if I think another path, such as regenerative medicine or a more basic metabolic workup, fits better, I will say so clearly.

The Liondale TPE Program

At Liondale, TPE is not sold as a menu item. We start with a consultation, a real review of history, and baseline labs before the first session is even discussed. That workup may include inflammatory markers, a metabolic panel, a lipid panel, and epigenetic clock biomarkers where they are clinically relevant (when they will actually change the decision-making). I review every case personally. Not a nurse coordinator. Not a remote medical sign-off. Me.

Most patients begin with an initial series of three to six sessions. Frequency is driven by baseline data, recovery, and response, not by a fixed package. Some patients do monthly sessions at first. Others space treatment every six to eight weeks. But there is no serious reason to force different bodies into the same calendar.

After the initial phase, maintenance is usually quarterly or monthly, depending on labs and goals. Patients already working with us through concierge medicine often appreciate that TPE sits inside a larger longevity strategy rather than off to the side. If someone is also using NAD+ IV therapy, hormone work, or other targeted support, we plan around that context instead of pretending each therapy exists in its own lane.

IVIG decisions are individualized. I am repeating that on purpose. The trial result that gets quoted most often used TPE with IVIG, but that does not make IVIG a default move for every patient who walks in the door. Protocol quality is not about adding more pieces. It is about using the right pieces for the right person.

How We Measure Results

The biggest mistake I see in this space is confusing experience with evidence. Feeling better matters. I care about that. But if you are investing in a procedure of this level, we should also be measuring what changed.

That is why Liondale includes a pre- and post-treatment lab panel with every session. We track inflammatory markers such as CRP, IL-6, and fibrinogen, plus a metabolic panel and lipid panel. Where clinically relevant, we also look at epigenetic clock biomarkers. The goal is simple: show whether the intervention moved something objective, not just whether the day after treatment felt good.

Kevin MacDonald, a 63-year-old Circulate Health patient, described it well: "Watching all my bloodwork numbers move into or towards the green gives me a lot of confidence in what I'm doing with TPE." I like that quote because it does not oversell the experience. It points to the right standard. Data first.

Circulate's post-procedure surveys report 90% patient satisfaction, which is useful as a patient experience measure but not the same thing as a clinical endpoint. Both matter. They are not interchangeable. Circulate's work has also been covered by the New York Times, Fortune, CNET, the Washington Post, and Axios, which tells you the topic has moved well beyond fringe longevity circles (a good sign, though not proof of efficacy by itself).

And measurement cuts both ways. If the data is not moving, the answer is not to pretend it is. It is to reassess, change course, or stop. That is part of good medicine too.

Safety Profile

TPE has more than 50 years of clinical use behind it, mainly in autoimmune and neurological medicine. That history matters because it means we are not improvising a brand-new procedure for longevity patients. In large retrospective datasets, serious adverse reactions occur in roughly 0.12% of procedures. For a treatment of this complexity, that is a reassuring profile.

The more common side effects are usually temporary: fatigue, lightheadedness, mild tingling related to calcium shifts during the session, and bruising at the IV site. Most resolve within 24 hours. Some patients bounce back quickly. Others need a quieter evening and more hydration. That variation is normal.

TPE is not appropriate for some candidates (and this is where screening matters). Contraindications include active bleeding disorders, certain clotting factor deficiencies, severe hemodynamic instability, and albumin allergy. Patients taking anticoagulants or certain immunosuppressants need careful review before treatment. Pre-consultation screening and baseline labs are designed to catch these issues before anyone is scheduled, not after a problem starts.

I am conservative about candidacy here. A premium practice should be more selective, not less. The goal is not to maximize sessions. The goal is to do the procedure when the risk-benefit profile makes sense.

Cost and Scheduling

We discuss Liondale pricing during consultation because the right protocol can vary meaningfully from one patient to another. Published pricing from other NYC TPE clinics ranges from $8,000 to $10,000 per session and higher. The full national picture, including what different program structures include and exclude, is covered on our TPE cost in NYC guide. The short version: cost varies meaningfully by protocol, and the gap between a bare procedure and a tracked, physician-reviewed program is larger than most patients expect.

At Liondale, the value is not just the procedure itself. It is the physician oversight, the Circulate-informed protocol structure, pre- and post-treatment lab tracking every session, individualized IVIG evaluation, and the fact that TPE is placed inside an integrated longevity plan rather than sold as an isolated event. That is the difference between a session and a program.

If you already know you want a physician-led TPE program in Manhattan, the next step is a consultation. Not a guessing game on package pricing.

Frequently Asked Questions

How many sessions will I need?

Most patients begin with three to six sessions. After that, maintenance may be monthly or quarterly depending on how your labs respond and what your goals are. There is no one-size-fits-all schedule, and I do not think there should be.

How long does each session take?

Most sessions take two to three hours from start to finish. You will usually have one or two IV lines placed, your vital signs are monitored during the procedure, and a certified apheresis nurse stays involved throughout. It is a medical session, but it is typically very manageable.

What labs are included at Liondale?

We include pre- and post-treatment testing with every session. That generally includes CRP, IL-6, fibrinogen, a metabolic panel, and a lipid panel, with epigenetic clock biomarkers added where clinically relevant. The purpose is to measure response, not just document that treatment occurred.

Can I combine TPE with NAD+ or ozone therapy?

Often, yes. Many patients pair TPE with therapies already used in a broader longevity plan, including NAD+ IV therapy and other physician-guided interventions. But timing matters (especially for recovery and hydration), so we sequence treatments intentionally rather than stacking them casually.

Who should NOT do TPE?

Patients with active bleeding disorders, certain clotting factor deficiencies, severe hemodynamic instability, or albumin allergy are generally not candidates. Patients on anticoagulants or some immunosuppressants need individual review before we proceed. If the fit is wrong, we will tell you directly.

How do I know if I'm responding to treatment?

We look at the data before and after each session. If inflammatory markers, metabolic markers, or relevant aging biomarkers are moving in the right direction, that supports response. If they are not, we reassess. Subjective improvement matters too, but objective tracking keeps the conversation honest.

What are the side effects of TPE?

The most common side effects are temporary fatigue, lightheadedness, mild tingling during the session from calcium shifts, and occasional bruising at the IV site. Most patients are back to baseline within 24 hours. Serious adverse events are uncommon, with large retrospective studies placing them at roughly 0.12% of procedures.

Does insurance cover TPE?

For longevity or anti-aging use, TPE is generally self-pay. Insurance coverage applies to certain established medical indications, not elective longevity protocols. If cost is part of your evaluation, our NYC TPE cost page gives a more complete breakdown of how pricing is usually structured.

Is plasmapheresis the same as TPE?

Yes. Plasmapheresis and therapeutic plasma exchange are often used interchangeably to describe the same core procedure: plasma is separated and removed, replacement fluid is infused, and blood cells are returned. The terminology changes. The mechanics do not.

How often do I need sessions for maintenance?

Maintenance is usually monthly or quarterly, but only after we see how you respond to the initial series. Some patients need closer follow-up at first. Others can space sessions out. Good maintenance planning is based on results, not assumption.

This page was written and reviewed by Lionel Bissoon, D.O., founder of Liondale Medical. Dr. Bissoon is a board-certified osteopathic physician specializing in anti-aging and concierge medicine on the Upper West Side of Manhattan. Liondale Medical is a Circulate Health partner.

This content is for educational purposes only and does not constitute medical advice. Individual results may vary. Consult a qualified physician before beginning any new treatment.